Nuclear factor-κB activation correlates with better prognosis and Akt activation in human gastric cancer

Clinical Cancer Research

Volumn 11, Issue 7, 2005, Pages 2518-2525

  Byung, Lan Lee ^a   Hye, Seung Lee ^a   Jung, Jieun ^a   Sung, Jin Cho ^a   Chung, Hee Yong ^b   Woo, Ho Kim ^c   Jin, Young Woo ^d   Chong, Soon Kim ^d   Seon, Young Nam ^a,d,e  

^a Seoul National University Bundang Hospital   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Div of Radiation Effect Research   (South Korea)

^e Korea Hydro & Nuclear Power Co   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KANGAI 1; LUCIFERASE; PROTEIN BCL 2; PROTEIN KINASE B; SMAD4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AKT1 PROTEIN, HUMAN; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; HYBRID PROTEIN; MESSENGER RNA; MORPHOLINE DERIVATIVE; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR RELA; WORTMANNIN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLON POLYPOSIS; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ASSAY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADOLESCENT; ADULT; AGED; CHILD; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; INFANT; MALE; METABOLISM; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROVIRUS; STOMACH TUMOR; SURVIVAL; TISSUE MICROARRAY; TUMOR CELL LINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANDROSTADIENES; BLOTTING, WESTERN; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMONES; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LUCIFERASES; MALE; MIDDLE AGED; MORPHOLINES; NEOPLASM STAGING; NF-KAPPA B; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 17644400134     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1282     Document Type: Article

References (31)

1. Saegusa M, Takano Y, Kamata Y, Okayasu J. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas. J Cancer Res Clin Oncol 1996;122:427-32.
2. Wu LB, Kushima R, Borchard F, Molsberger G, Hattori T. Intramucosal carcinomas of the stomach: phenotypic expression and loss of heterozygosity at microsatellites linked to the APC gene. Pathol Res Pract 1998;194:405-11.
3. Endoh Y, Sakata K, Tamura G, et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathway. J Pathol 2000;191:257-63.
4. Oya M, Takayanagi A, Horiguchi A, et al. Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003;24:377-84.
5. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003;22:50-8.
6. Abdel-Latif MM, O'Riordan J, Windle HJ, et al. NF-κB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neo-adjuvant chemoradiotherapy. Ann Surg 2004;239:491-500.
7. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res 2000;60:4085-92.
8. Fujioka S, Sclabas GM, Schmidt C, et al. Function of nuclear factor κB in pancreatic cancer metastasis. Clin Cancer Res 2003;9:346-54.
9. Varro A, Noble P-JM, Pritchard M, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-κB and RhoA: implications for invasion and apoptosis. Cancer Res 2004;64:1695-702.
10. Sasaki N, Morisaki T, Hashizume K, et al. Nuclear Factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001;7:4136-42.
11. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003;200:39-46.
12. Lee JH, Seo YW, Park SR, Kim YJ, Kim KK. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 2003;63:7247-55.
13. Shinohara T, Miki T, Nishimura N, et al. Nuclear factor-κB- dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Cancer Res 2001;61:673-8.
14. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-5.
15. Madrid LV, Wang C-Y, Guttridge DC, Schottelius AJG, Baldwin AS Jr, Marty WM. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 2000;20:1626-38.
16. Mansell A, Khelef N, Cossart P, O'Neill LAJ. Internalin B activates nuclear factor-κB via Ras, phosphoinositide 3-kinase, and Akt. J Biol Chem 2001;276:43597-603.
17. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. Interferon α/β promotes cell survival by activating nuclear factor κB through phosphatidylinositol 3-kinase and Akt. J Biol Chem 2001;276:13756-61.
18. Birkenkamp KU, Geugien M, Schepers H, Westra J, Lemmink HH, Vellenga E. Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway. Leukemia 2004;18:103-12.
19. Delhase M, Li N, Karin M. Kinase regulation in inflammatory response. Nature 2000;406:367-8.
20. Shao R, Tsai EM, Wei K, et al. E1A inhibition of radiation-induced NF-κB activity through suppression of IKK activity and IκB degradation, independent of Akt activation. Cancer Res 2001;61:7413-6.
21. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas. Cancer 2001;92:1427-34.
22. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
23. Nam SY, Lee HS, Jung G-A, et al. Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis. APMIS 2003;111: 1105-13.
24. Oh SC, Nam SY, Kwon HC, et al. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron. Mol Cells 2001;11:192-7.
25. S by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers. Cancer Sci 2003;94:1066-73.
26. Okusa Y, Ichikura T, Mochizuki H. Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer 1999;85: 1033-8.
27. Kim SJ, Kim YH. Molecular markers in gastric cancer: can they predict prognosis? Cancer Res Treat 2003;35:1-2.
28. Perez-Tenorio G, Stal O. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer 2002;86:540-5.
29. Schlieman MG, Fahy BN, Ramsamooj R, Beckett L, Bold RJ. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer 2003;89:2110-5.
30. Panigrahi AR, Pinder SE, Chan SY, Paish EC, Pobertson JFR, Ellis IO. The role of PTEN and its signaling pathways, including AKT, in breast cancer: an assessment of relationships with other prognostic factors and with outcome. J Pathol 2004;204:93-100.
31. Massion PP, Taflan PM, Shyr Y, et al. Early involvement of the phophatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med 2004;170:1088-94.